drugset / Trial / NCT07354126

Comparative Efficacy of Flunarizine and Propanolol in Pediatric Migraine

NCT07354126

Recruiting 44 enrolled Muhammad Aamir Latif
RandomizedParallel-groupOpen-labelTreatment

Summary

Flunarizine and propranolol have demonstrated efficacy in reducing migraine frequency across age groups, though evidence in pediatric populations remains limited and inconsistent. Therefore, the current study has been planned to evaluate and compare the effectiveness of flunarizine and propranolol in reducing migraine frequency in children aged 8-15 using the Pediatric Migraine Disability Assessment Scale (PedMIDAS) score.

Timeline

Start
2025-09-01
Primary completion
2026-02-28
Completion
2026-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Flunarizine Small molecule 10 mg
Subject Propranolol Small molecule 60 mg

Indications